Original Article
INTRODUCTIONCisplatin is an antineoplastic agent often used in malign neoplasms such as those in gastrointestinal systems, urinary system, and head and neck. Although it has successful results against cancer, there are restrictions in clinical use due to serious side effects such as gastrointestinal, peripheral neuropathic, nephropathic, bone marrow toxicity, and ototoxicity [1,2] . The increase in calcium rate is due to inner cellular calcium channel blockage in cochlear cells in cisplatin-induced ototoxicity; and increase electrolyte in imbalance and lipid peroxidation is due to the disruption in cell membrane, antioxidant system disruption, and emergence of free radicals such as oxygen and nitrogen [3][4][5][6] . As a result of these, progressive and irreversible sensorineural hearing loss in high frequencies and continuous or discontinuous tinnitus develops. In the studies conducted, it was shown that outer hairy cells in cisplatin cochlea, spiral ganglion cells (SGC), and cochlea basal and mid-turn parts in cochlea and Reissner's membrane and stria vascularis are affected [3,7,8] .In literature, different antioxidant agents such as vitamin E [9] , N-acetylcysteine [10] , dexamethasone [11] , lycopene [12] , and Ginkgo biloba [13] used in cisplatin-induced ototoxicity have been mentioned. Lycopene and G. biloba are also antioxidant agents. G. biloba contains biloba extract, EGb 761, 24% flavone glycosides, 6% terpene lactones, and 7% proanthocyaniclines which are strong antioxidants (14). In different in vivo and in vitro studies, it was shown that G. biloba prevents oxidative stress and has a role in the cleaning of free radicals [15,16] .